Provention Bio Statistics Share Statistics Provention Bio has 95.09M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 95.09M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 69.61M Failed to Deliver (FTD) Shares 3,056,559 FTD / Avg. Volume 107.51%
Short Selling Information The latest short interest is 5.37M, so 0% of the outstanding
shares have been sold short.
Short Interest 5.37M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.33
Valuation Ratios The PE ratio is -6.95 and the forward
PE ratio is null.
Provention Bio's PEG ratio is
0.43.
PE Ratio -6.95 Forward PE n/a PS Ratio 61.25 Forward PS n/a PB Ratio 6.48 P/FCF Ratio -10.36 PEG Ratio 0.43
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Provention Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.93,
with a Debt / Equity ratio of 0.2.
Current Ratio 1.93 Quick Ratio 1.92 Debt / Equity 0.2 Debt / EBITDA -0.19 Debt / FCF -0.31 Interest Coverage -123.59
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $74.11K Profits Per Employee $-652.67K Employee Count 174 Asset Turnover 0.05 Inventory Turnover 0.42
Taxes Income Tax -13.39M Effective Tax Rate 10.55%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 2.46, so Provention Bio's
price volatility has been higher than the market average.
Beta 2.46 52-Week Price Change n/a 50-Day Moving Average 18.81 200-Day Moving Average 9.94 Relative Strength Index (RSI) 80.19 Average Volume (20 Days) 2,842,990
Income Statement In the last 12 months, Provention Bio had revenue of 12.89M
and earned -113.56M
in profits. Earnings per share was -1.52.
Revenue 12.89M Gross Profit 12.38M Operating Income -128.16M Net Income -113.56M EBITDA -124.69M EBIT -125.92M Earnings Per Share (EPS) -1.52
Full Income Statement Balance Sheet The company has 44.04M in cash and 23.91M in
debt, giving a net cash position of 20.13M.
Cash & Cash Equivalents 44.04M Total Debt 23.91M Net Cash 20.13M Retained Earnings -405.64M Total Assets 236.86M Working Capital 84.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -75.41M
and capital expenditures -795K, giving a free cash flow of -76.2M.
Operating Cash Flow -75.41M Capital Expenditures -795K Free Cash Flow -76.2M FCF Per Share -1.02
Full Cash Flow Statement Margins Gross margin is 96.03%, with operating and profit margins of -993.88% and -880.69%.
Gross Margin 96.03% Operating Margin -993.88% Pretax Margin -984.54% Profit Margin -880.69% EBITDA Margin -966.98% EBIT Margin -993.88% FCF Margin -590.95%
